Karolinska Development is a private equity general partner firm headquartered in Solna, Sweden.
Swedish life sciences VC Karolinska Development has appointed Viktor Drvota as chief investment officer, replacing deputy CEO Terje Kalland.
Karolinska Development sold its holding in drug development firm Athera Biotechnologies to Östersjöstiftelsen and Industrifonden for SEK24m.
Swedish medical tech company OssDsign has secured €9.6m in funding from SEB Venture Capital, Fouriertransform and Karolinska Development.
Read more news concerning Karolinska Development
A sampling of Karolinska Development portfolio companies:
View all of the investments in their portfolio
Registration is fast, free and easy
Already a member?